Healthcare Industry News: AbsorbaTack
News Release - January 17, 2008
Covidien Introduces AbsorbaTack(TM) 5mm Hernia Fixation Device Featuring Absorbable Tacks
Surgical Devices Global Business Unit Provides Comprehensive Solutions for Soft Tissue RepairNORTH HAVEN, Conn.--(HSMN NewsFeed)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the U.S. introduction of the AbsorbaTack™ 5mm absorbable mesh fixation device for hernia repair, one of the most performed surgical procedures worldwide.
The AbsorbaTack™ 5mm absorbable tacks provide strong mesh attachment to the surrounding tissues, while reducing the amount of foreign material remaining in the patient long-term. Coupling the absorbable fixation of the AbsorbaTack™ with Covidien’s Parietex™ mesh, a hydrophilic polyester mesh that establishes fast intimate tissue integration, offers an appropriate clinical solution. These leading innovative products were designed in collaboration with surgeons, keeping patient comfort in mind.
“We are changing the way surgeons approach soft tissue repair,” said Scott Flora, President, Surgical Devices, Covidien. “The success of this new device will strengthen Covidien’s position as a market leader providing comprehensive solutions for hernia repair,” added Flora.
“Absorbable fixation that is as effective and easy to use as Covidien’s ProTack™ is ideal.” said Dr. Bruce Ramshaw MD, FACS, Associate Professor, Chief, Division of General Surgery, University of Missouri. “And since AbsorbaTack™ is a 5 millimeter device , we can use it for the laparoscopic ventral hernia as well as a laparoscopic inguinal repair,” added Dr. Ramshaw. For more information on AbsorbaTack™ please visit www.AbsorbaTack.com
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Medical Devices, Pharmaceutical Products, Imaging Solutions, Medical Supplies and Retail Products. With 2007 revenue of $10 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.
Source: Covidien
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
